Sartorius Stedim Biotech SA / Key word (s): Annual Results/Quarter Results Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 28-Jan-2025 / 07:04 CET/CEST ...
The Nutrigenomics Market has been garnering significant attention in recent years, driven by growing consumer awareness about ...
The Transcranial Magnetic Stimulator Market has witnessed remarkable growth in recent years. Valued at USD 1.22 billion in ...
The Cold Storage Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers ...
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
The Clinical Trials Market report delivers crucial insights into the market's growth trajectory and the primary revenue ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
Preliminary ResultsEckert & Ziegler Announces Preliminary Figures for 2024: Significant Increase in Sales and Adjusted EBIT27-Jan-2025 / 18:55 CET/CESTDisclosure of an inside information acc. to ...
The medical robotics industry has undergone significant transformations in recent years, driven by technological advancements, increasing demand for precision in medical procedures, and the growing ...
The Biotechnology Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers ...
CapeStart Closes 2024 with New Client Growth, Strategic Hires, and the Launch of MadeAi™, the Award-winning GenAI-enabled Platform A Banner Year for the Life Sciences GenAI Services and Solutions ...
Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous administration.